BR9915571A - Benzilmaltosìdeos como inibidores de proliferação de célula muscular lisa - Google Patents

Benzilmaltosìdeos como inibidores de proliferação de célula muscular lisa

Info

Publication number
BR9915571A
BR9915571A BR9915571-0A BR9915571A BR9915571A BR 9915571 A BR9915571 A BR 9915571A BR 9915571 A BR9915571 A BR 9915571A BR 9915571 A BR9915571 A BR 9915571A
Authority
BR
Brazil
Prior art keywords
inhibitors
cell proliferation
muscle cell
smooth muscle
benzylmaltosides
Prior art date
Application number
BR9915571-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul Jeffrey Dollings
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9915571A publication Critical patent/BR9915571A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9915571-0A 1998-11-24 1999-11-23 Benzilmaltosìdeos como inibidores de proliferação de célula muscular lisa BR9915571A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19843498A 1998-11-24 1998-11-24
PCT/US1999/027824 WO2000031100A2 (fr) 1998-11-24 1999-11-23 Benzylmaltosides utilises comme inhibiteurs de la proliferation cellulaire des muscles lisses

Publications (1)

Publication Number Publication Date
BR9915571A true BR9915571A (pt) 2001-08-14

Family

ID=22733369

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915571-0A BR9915571A (pt) 1998-11-24 1999-11-23 Benzilmaltosìdeos como inibidores de proliferação de célula muscular lisa

Country Status (7)

Country Link
EP (1) EP1133512A2 (fr)
JP (1) JP2002530424A (fr)
CN (1) CN1333784A (fr)
AU (1) AU1743900A (fr)
BR (1) BR9915571A (fr)
CA (1) CA2350753A1 (fr)
WO (1) WO2000031100A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034295A2 (fr) * 1998-11-24 2000-06-15 American Home Products Corporation Benzylmaltosides acyles, inhibiteurs de proliferation des cellules des muscles lisses
CN105367614B (zh) * 2015-11-24 2019-02-22 中国人民解放军第二军医大学 含有葡萄糖类脂肪酸衍生物的制备方法及其在医药领域的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them
AU1743800A (en) * 1998-11-24 2000-06-26 American Home Products Corporation Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation

Also Published As

Publication number Publication date
CN1333784A (zh) 2002-01-30
CA2350753A1 (fr) 2000-06-02
EP1133512A2 (fr) 2001-09-19
WO2000031100A2 (fr) 2000-06-02
AU1743900A (en) 2000-06-13
JP2002530424A (ja) 2002-09-17
WO2000031100A3 (fr) 2000-11-23

Similar Documents

Publication Publication Date Title
BR9916223A (pt) 4-ariloxindóis como inibidores de cinases de proteìna jnk
CY1116988T1 (el) Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β
BR0210652A (pt) Pirrolopirimidinas como inibidores de proteìnas cinases
DE69911448D1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
BR9909242A (pt) Inibidores de fosfolipase a2
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
NO972043L (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
DE60025848D1 (en) Pyrimidin-derivate als selective inhibitoren von cox-2
NO975666D0 (no) Pyrroldovater og medisinsk sammensetning
BR9916324A (pt) 4,5-pirazinoxindóis como inibidores de proteìna quinase
PT998287E (pt) Utilizacao de levobupivacaina
BR9914355A (pt) Derivados de mononitrato de isosorbida e sua utilização como agentes vasodilatadores com tolerância reduzida
BR9813208A (pt) Antagonista receptor de vitronectina
BR9908882A (pt) Bisindolimaleimidas substituìdas para a inibição de proliferação de célula
BR9813996A (pt) 2-arilbenzo[b]tiofenos úteis para o tratamento de sìndrome da privação de estrogênio
ATE295183T1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
ZA972778B (en) 4-[(thien-2-yl)methyl]-imidazole analgesics
FR2847899B1 (fr) Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
FR2771727B1 (fr) Defluoruration d'eaux usees
BR9915571A (pt) Benzilmaltosìdeos como inibidores de proliferação de célula muscular lisa
BR0015483A (pt) Feniluracilas substituìdas e sua aplicação como herbicidas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired